Kurt L. Krause
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kurt L. Krause has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Ulrich Strych
Texas Children’s Hospital Center for Vaccine Development, Houston, TX 77030, USA
2 shared publications Daniel L. Milligan
Department of Biochemistry, Otago School of Medical Sciences, University of Otago, P.O. Box 56, Dunedin, New Zealand
1 shared publication- Eileen L Murphy
University of Houston, Department of Biology and Biochemistry, 4800 Calhoun Rd, Houston, TX 77204-5001, USA
1 shared publication Gregory M. Cook
Department of Biochemistry,1 Department of Microbiology and Immunology, Otago School of Medical Sciences, University of Otago, P.O. Box 56, Dunedin, New Zealand,2 Department of Biology and Biochemistry, University of Houston, Houston, Texas 77204-50013
1 shared publication- Hookang Im
Research Institute of Pharmaceutical Sciences, College of Pharmacy, Seoul National University, Seoul 08826, Republic of Korea
1 shared publication - Joseph P Longtin
University of Houston, Department of Biology and Biochemistry, 4800 Calhoun Rd, Houston, TX 77204-5001, USA
1 shared publication
Latest Publications
- 15 November 2007
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 189 (22) , 8381-8386
The Alanine Racemase of Mycobacterium smegmatis Is Essential for Growth in the Absence of d -Alanine
Alanine racemase, encoded by the gene alr , is an important enzyme in the synthesis of d -alanine for peptidoglycan biosynthesis. Strains of Mycobacterium smegmatis with a deletion mutation of the alr gene were found to require d -alanine for growth in both rich and minimal media. This indicates that alanine racemase is the only source of d -alanine for cell wall biosynthesis in M. smegmatis and confirms alanine racemase as a viable target gene for antimycobacterial drug development.
- 15 November 2007
- Published by American Society for Microbiology in Journal of Bacteriology
- Vol. 189 (22) , 8381-8386
The Alanine Racemase of Mycobacterium smegmatis Is Essential for Growth in the Absence of d -Alanine
Alanine racemase, encoded by the gene alr , is an important enzyme in the synthesis of d -alanine for peptidoglycan biosynthesis. Strains of Mycobacterium smegmatis with a deletion mutation of the alr gene were found to require d -alanine for growth in both rich and minimal media. This indicates that alanine racemase is the only source of d -alanine for cell wall biosynthesis in M. smegmatis and confirms alanine racemase as a viable target gene for antimycobacterial drug development.
- Open Access
- 17 May 2007
- Published by Springer Nature in BMC Microbiology
- Vol. 7 (1) , 40
Purification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae
Background: Over the past fifteen years, antibiotic resistance in the Gram-positive opportunistic human pathogen Streptococcus pneumoniae has significantly increased. Clinical isolates from patients with community-acquired pneumonia or otitis media often display resistance to two or more antibiotics. Given the need for new therapeutics, we intend to investigate enzymes of cell wall biosynthesis as novel drug targets. Alanine racemase, a ubiquitous enzyme among bacteria and absent in humans, provides the essential cell wall precursor, D-alanine, which forms part of the tetrapeptide crosslinking the peptidoglycan layer. Results: The alanine racemases gene from S. pneumoniae (alr SP ) was amplified by PCR and cloned and expressed in Escherichia coli. The 367 amino acid, 39854 Da dimeric enzyme was purified to electrophoretic homogeneity and preliminary crystals were obtained. Racemic activity was demonstrated through complementation of an alr auxotroph of E. coli growing on L-alanine. In an alanine racemases photometric assay, specific activities of 87.0 and 84.8 U mg-1 were determined for the conversion of D- to L-alanine and L- to D-alanine, respectively. Conclusion: We have isolated and characterized the alanine racemase gene from the opportunistic human pathogen S. pneumoniae. The enzyme shows sufficient homology with other alanine racemases to allow its integration into our ongoing structure-based drug design project.
- 17 May 2007
- Published by Springer Nature in BMC Microbiology
- Vol. 7 (1) , 40
Open AccessPurification and preliminary crystallization of alanine racemase from Streptococcus pneumoniae
Background: Over the past fifteen years, antibiotic resistance in the Gram-positive opportunistic human pathogen Streptococcus pneumoniae has significantly increased. Clinical isolates from patients with community-acquired pneumonia or otitis media often display resistance to two or more antibiotics. Given the need for new therapeutics, we intend to investigate enzymes of cell wall biosynthesis as novel drug targets. Alanine racemase, a ubiquitous enzyme among bacteria and absent in humans, provides the essential cell wall precursor, D-alanine, which forms part of the tetrapeptide crosslinking the peptidoglycan layer. Results: The alanine racemases gene from S. pneumoniae (alr SP ) was amplified by PCR and cloned and expressed in Escherichia coli. The 367 amino acid, 39854 Da dimeric enzyme was purified to electrophoretic homogeneity and preliminary crystals were obtained. Racemic activity was demonstrated through complementation of an alr auxotroph of E. coli growing on L-alanine. In an alanine racemases photometric assay, specific activities of 87.0 and 84.8 U mg-1 were determined for the conversion of D- to L-alanine and L- to D-alanine, respectively. Conclusion: We have isolated and characterized the alanine racemase gene from the opportunistic human pathogen S. pneumoniae. The enzyme shows sufficient homology with other alanine racemases to allow its integration into our ongoing structure-based drug design project.